Addressing Social Determinants of Health in Child Obesity Treatment Using Community Health Workers
Launched by CHILDREN'S MERCY HOSPITAL KANSAS CITY · Jul 23, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Family must have one major social risk factor on the Protocol for Responding to \& Assessing Patients' Assets, Risks \& Experiences (PRAPARE) of the 14 modifiable risk factors
- • Child aged 8 through 12 years of age
- • Child with BMI% at 85th percentile or higher and less than the 120% of the 95th percentile (overweight or class 1 obesity)
- • Child must live with parent/guardian at least 5 out of the 7 days on average (70% of the time)
- • Child and parent able to speak English
- Exclusion Criteria:
- • Child on medications known to cause ongoing weight gain (e.g., atypical anti-psychotics, chronic prednisone, insulin)
- • Child on other medications know to affect weight if dose and BMI z-score has not been stable for 3 months.
- • Diabetes or other disease that has a significant effect on diet, physical activity, or ability to take part in trial activities besides obesity (does not included treated or mild depression or anxiety, limited food allergies or mild physical activity limitations)
- • For parents: new MI, stroke or cancer diagnosis (excluding localized skin cancers) in past 6 months, history of bariatric surgery within the past 3 years, pregnancy in last 6 months or planned within 1 year
- • Child or parent has significant developmental or cognitive impairments or other significant medical issue that would interfere with ability to participate or complete assessment
- • Parent or child has significant physical limitation
- • Parent/child planning to move to from Children's Mercy Kansas City (CMKC) service area
About Children's Mercy Hospital Kansas City
Children's Mercy Hospital Kansas City is a renowned pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative research and clinical trials. As a leading sponsor of clinical trials, the hospital focuses on developing and testing new treatments and therapies that address a wide range of pediatric conditions. With a commitment to excellence in patient care and a collaborative approach to research, Children's Mercy is at the forefront of pediatric medicine, striving to improve outcomes and enhance the quality of life for children and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Missouri, United States
Patients applied
Trial Officials
Helena Laroche, MD
Principal Investigator
Children's Mercy Kansas City
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported